Published in Anesthesiology on June 01, 2013
PCC vs. FFP for Post Cardiopulmonary Bypass Coagulopathy and Bleeding | NCT02557672
Factor eight inhibitor bypass activity for novel oral anticoagulant reversal. Anesthesiology (2014) 1.09
Management of non-vitamin K antagonist oral anticoagulants in the perioperative setting. Biomed Res Int (2014) 0.87
Management of Patients on Non-Vitamin K Antagonist Oral Anticoagulants in the Acute Care and Periprocedural Setting: A Scientific Statement From the American Heart Association. Circulation (2017) 0.82
Rivaroxaban-Induced Nontraumatic Spinal Subdural Hematoma: An Uncommon Yet Life-Threatening Complication. Case Rep Hematol (2015) 0.80
Neuraxial and peripheral nerve blocks in patients taking anticoagulant or thromboprophylactic drugs: challenges and solutions. Local Reg Anesth (2015) 0.77
Updates in the perioperative and emergency management of non-vitamin K antagonist oral anticoagulants. Crit Care (2015) 0.77
Management of antithrombotic therapy during cardiac implantable device surgery. J Arrhythm (2016) 0.77
Preventive strategies against bleeding due to nonvitamin K antagonist oral anticoagulants. Biomed Res Int (2014) 0.76
Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation. Crit Care (2016) 0.76
Novel Oral Anticoagulants for Venous Thromboembolism with Special Emphasis on Risk of Hemorrhagic Complications and Reversal Agents. Curr Drug ther (2016) 0.75
Perioperative Considerations and Management of Patients Receiving Anticoagulants. Anesth Essays Res (2017) 0.75
Periprocedural Management of Non-Vitamin K Oral Anticoagulants in Chronic Kidney Disease: A Review of Existing Heterogeneity and Contemporary Evidence. J Atr Fibrillation (2015) 0.75
Newer Oral Anticoagulants: Stroke Prevention and Pitfalls. Open Cardiovasc Med J (2016) 0.75
In reply. Anesthesiology (2014) 0.75
Perioperative management of the bleeding patient. Br J Anaesth (2016) 0.75
2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation. J Arrhythm (2017) 0.75
Viscoelastic testing inside and beyond the operating room. J Thorac Dis (2017) 0.75
Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 16.17
2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary]. CMAJ (2007) 9.10
Systematic overview of warfarin and its drug and food interactions. Arch Intern Med (2005) 5.86
Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates. Circulation (2012) 3.74
Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients. Ann Intern Med (2007) 3.33
Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis. Ann Intern Med (2003) 3.18
Oral vitamin K lowers the international normalized ratio more rapidly than subcutaneous vitamin K in the treatment of warfarin-associated coagulopathy. A randomized, controlled trial. Ann Intern Med (2002) 2.85
Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) - March 2013. Arch Cardiovasc Dis (2013) 2.71
D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study. Ann Intern Med (2015) 2.63
Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism. Ann Intern Med (2008) 2.51
Combined aspirin-oral anticoagulant therapy compared with oral anticoagulant therapy alone among patients at risk for cardiovascular disease: a meta-analysis of randomized trials. Arch Intern Med (2007) 2.50
Statins and intracerebral hemorrhage: collaborative systematic review and meta-analysis. Circulation (2011) 2.17
Selective D-dimer testing for diagnosis of a first suspected episode of deep venous thrombosis: a randomized trial. Ann Intern Med (2013) 2.09
The management of patients who require temporary reversal of vitamin K antagonists for surgery: a practical guide for clinicians. Intern Emerg Med (2006) 2.05
Risk of deep vein thrombosis following a single negative whole-leg compression ultrasound: a systematic review and meta-analysis. JAMA (2010) 1.64
Dental surgery for patients on anticoagulant therapy with warfarin: a systematic review and meta-analysis. J Can Dent Assoc (2009) 1.52
Detection of pulmonary emboli with 99mTc-labeled anti-D-dimer (DI-80B3)Fab' fragments (ThromboView). Am J Respir Crit Care Med (2011) 1.51
Dosing practices and risk factors for bleeding in patients receiving enoxaparin for the treatment of an acute coronary syndrome. Chest (2004) 1.42
Regional anaesthesia and antithrombotic agents: recommendations of the European Society of Anaesthesiology. Eur J Anaesthesiol (2010) 1.37
Patient outcomes after deep vein thrombosis and pulmonary embolism: the Worcester Venous Thromboembolism Study. Arch Intern Med (2008) 1.36
How I treat anticoagulated patients undergoing an elective procedure or surgery. Blood (2012) 1.31
The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society guidelines. Can J Cardiol (2011) 1.25
DHCR7 mutation carrier rates and prevalence of the RSH/Smith-Lemli-Opitz syndrome: where are the patients? Am J Med Genet A (2006) 1.09
ESA guidelines on the management of severe perioperative bleeding: comments on behalf of the Subcommittee on Transfusion and Haemostasis of the European Association of Cardiothoracic Anaesthesiologists. Eur J Anaesthesiol (2014) 1.07
Factors that predict risk of thrombosis in relatives of patients with unprovoked venous thromboembolism. Chest (2009) 1.03
Low-dose oral vitamin K to normalize the international normalized ratio prior to surgery in patients who require temporary interruption of warfarin. J Thromb Thrombolysis (2007) 0.99
Are brand-name and generic warfarin interchangeable? Multiple n-of-1 randomized, crossover trials. Ann Pharmacother (2005) 0.96
Incidence of Smith-Lemli-Opitz syndrome in Canada: results of three-year population surveillance. J Pediatr (2004) 0.95
Different anesthetic techniques associated with different incidences of chronic post-thoracotomy pain: low-dose remifentanil plus presurgical epidural analgesia is preferable to high-dose remifentanil with postsurgical epidural analgesia. J Cardiothorac Vasc Anesth (2009) 0.94
Accuracy of emergency physician-performed ultrasonography in the diagnosis of deep-vein thrombosis: a systematic review and meta-analysis. Thromb Haemost (2012) 0.93
Device surgery without interruption of anticoagulation. N Engl J Med (2013) 0.92
The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society Guidelines Executive Summary. Can J Cardiol (2011) 0.88
Use of a clinical prediction score in patients with suspected deep venous thrombosis: two steps forward, one step back? Ann Intern Med (2005) 0.87
Patient preferences for capillary vs. venous INR determination in an anticoagulation clinic: a randomized controlled trial. Thromb Res (2004) 0.86
Perioperative coagulation management in the intensive care unit. Curr Opin Anaesthesiol (2013) 0.85
Management of hypertension in overweight and obese patients: a practical guide for clinicians. Curr Hypertens Rep (2005) 0.84
Strategies to enhance venous thromboprophylaxis in hospitalized medical patients (SENTRY): a pilot cluster randomized trial. Implement Sci (2013) 0.84
Routine use of ultrasound to guide internal jugular vein access in children. Paediatr Anaesth (2010) 0.84
Surgery and invasive procedures in patients on long-term treatment with direct oral anticoagulants: thrombin or factor-Xa inhibitors. Recommendations of the Working Group on Perioperative Haemostasis and the French Study Group on Thrombosis and Haemostasis. Arch Cardiovasc Dis (2011) 0.84
Deep vein thrombosis prophylaxis in hospitalized medical patients: current recommendations, general rates of implementation, and initiatives for improvement. Clin Chest Med (2010) 0.83
The clinical impact of bleeding during oral anticoagulant therapy: assessment of morbidity, mortality and post-bleed anticoagulant management. J Thromb Thrombolysis (2011) 0.83
Are brand-name and generic warfarin interchangeable? A survey of Ontario patients and physicians. Can J Clin Pharmacol (2005) 0.83
Barriers and potential solutions toward optimal prophylaxis against deep vein thrombosis for hospitalized medical patients: a survey of healthcare professionals. J Hosp Med (2011) 0.82
Preventing venous thromboembolism in long-term care residents: Cautious advice based on limited data. Cleve Clin J Med (2010) 0.82
Safety of continuing warfarin therapy during cataract surgery: a systematic review and meta-analysis. Thromb Res (2009) 0.80
Patient-level compared with study-level meta-analyses demonstrate consistency of D-dimer as predictor of venous thromboembolic recurrences. J Clin Epidemiol (2013) 0.80
Body weight classification. CMAJ (2005) 0.79
What's new in management of traumatic coagulopathy? Intensive Care Med (2014) 0.79
Red Blood Cell Transfusion and Massive Bleeding in Children Undergoing Heart Transplant. Anesth Analg (2016) 0.78
Prevention of venous thromboembolism in the Enhanced Recovery After Surgery (ERAS) setting: an evidence-based review. Can J Anaesth (2014) 0.78
Prognostic significance of residual venous obstruction in patients with treated unprovoked deep vein thrombosis: a patient-level meta-analysis. Thromb Haemost (2013) 0.78
Management of the clotting system: a European perspective. Curr Opin Anaesthesiol (2012) 0.78
Blood storage duration and morbidity and mortality in children undergoing cardiac surgery. A retrospective analysis. Eur J Anaesthesiol (2014) 0.78
Alternatives to preoperative transfusion should be preferred in anemic cardiac surgical patients instead of useless transfusion. Anesthesiology (2012) 0.77
Effective tranexamic acid concentration for 95% inhibition of tissue-type plasminogen activator induced hyperfibrinolysis in children with congenital heart disease: A prospective, controlled, in-vitro study. Eur J Anaesthesiol (2015) 0.77
Dental surgery for patients on anticoagulant therapy with warfarin: a systematic review and meta-analysis. Tex Dent J (2009) 0.77
Management of bleeding in patients receiving conventional or new anticoagulants: a practical and case-based approach. Drugs (2012) 0.77
Perioperative management of warfarin therapy: to bridge or not to bridge, that is the question. Mayo Clin Proc (2008) 0.77
Oral vitamin K produces a normal INR within 24 hours of its administration in most patients discontinuing warfarin. Haematologica (2005) 0.76
Perioperative management of patients having noncardiac surgery who are receiving anticoagulant or antiplatelet therapy: an evidence-based but practical approach. Semin Thromb Hemost (2012) 0.76
Combined warfarin-aspirin therapy: what is the evidence for benefit and harm and which patients should (and should not) receive it? J Thromb Thrombolysis (2010) 0.76
Antifibrinolytic Therapy for Cardiac Surgery: An Update. Anesthesiology (2015) 0.76
Review of the fibrinolytic system: comparison of different antifibrinolytics used during cardiopulmonary bypass. Recent Pat Cardiovasc Drug Discov (2012) 0.76
Low-molecular-weight heparins for the treatment of acute coronary syndrome and venous thromboembolism in patients with chronic renal insufficiency. Thromb Res (2005) 0.76
Bridging Anticoagulation in Patients with Atrial Fibrillation. N Engl J Med (2016) 0.75
Restarting antithrombotics after GI bleeding was linked to better outcomes in patients with AF. Ann Intern Med (2016) 0.75
Response. Chest (2014) 0.75
Ruling out DVT using the Wells rule and a D-dimer test. BMJ (2014) 0.75
Erythrocyte transfusion: a fair balance. Anesthesiology (2011) 0.75
The association between venous thromboembolism and physical inactivity in everyday life. BMJ (2011) 0.75
Use of tranexamic acid in pediatric cardiac surgery: we really need more. J Anesth (2011) 0.75
Response. Chest (2013) 0.75
Can we really believe that aprotinin is safe in congenital heart surgery? Ann Thorac Surg (2011) 0.75
Algorithm-based management of bleeding in patients with extracorporeal membrane oxygenation. Crit Care (2013) 0.75
Safety of tranexamic acid in pediatric cardiac surgery: what we do not know. Eur J Cardiothorac Surg (2011) 0.75
Perioperative anticoagulant management in patients with atrial fibrillation : practical implications of recent clinical trials. Pol Arch Med Wewn (2015) 0.75
Tranexamic acid could really be recommended in case of subarachnoid hemorrhage? Neurosurgery (2011) 0.75
Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: First update 2016. Eur J Anaesthesiol (2017) 0.75
Efficacy and safety of aprotinin in paediatric cardiac surgery: A systematic review and meta-analysis. Eur J Anaesthesiol (2022) 0.75
Editorial: management of perioperative systemic inflammation during cardiopulmonary bypass: we need a multimodal approach. Recent Pat Cardiovasc Drug Discov (2012) 0.75
Open access to research data: the two sides of the coin. Eur J Anaesthesiol (2017) 0.75
Risk factors of post-dural puncture headache receiving a blood patch in obstetric patients. Minerva Anestesiol (2015) 0.75
Periprocedural anticoagulation practices in warfarin-treated patients who require elective angiography with or without percutaneous coronary intervention: a retrospective chart review. Thromb Res (2009) 0.75
Management of patients who are receiving warfarin or a new oral anticoagulant and require urgent or emergency surgery. Pol Arch Med Wewn (2012) 0.75
Artefact in the electroencephalographic monitoring in a patient with brain metastasis. Eur J Anaesthesiol (2010) 0.75
Combination of ultrasonographic supraclavicular block and general anaesthesia for arthroscopic shoulder surgery in a patient with haemophilia A. Eur J Anaesthesiol (2014) 0.75
Comparison of pain and ecchymosis with low-molecular-weight heparin vs. unfractionated heparin in patients requiring bridging anticoagulation after warfarin interruption: a randomized trial. J Thromb Thrombolysis (2009) 0.75
Are heparins anti-neoplastic agents? Pol Arch Med Wewn (2008) 0.75
Influence of warfarin on symptoms of fatigue: findings of a randomized trial. Ann Pharmacother (2005) 0.75
Prevention and treatment of hormone-associated venous thromboembolism: a patient management approach. Hematol Oncol Clin North Am (2010) 0.75
An early, multimodal, goal-directed approach of coagulopathy in the bleeding traumatized patient. Curr Opin Anaesthesiol (2013) 0.75
Is there a role for novel oral anticoagulants in patients with an acute coronary syndrome? A review of the clinical trials. Pol Arch Med Wewn (2013) 0.75
Does celecoxib potentiate the anticoagulant effect of warfarin? A randomized, double-blind, controlled trial. Ann Pharmacother (2006) 0.75
Why A-level evidence does not make it to clinicians' A-lists: the case of thromboprophylaxis in medical patients. ACP J Club (2008) 0.75